chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 10 month old patient of unknown gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On an unknown date the patient was vaccinated with a dose of VAQTA (lot #, expiration date, dose and route not provided). No adverse effects were reported. Additional information has been requested.
Redness and swelling on site that was noticed after the Corpsman asked them to remove their blouse so he could check on the site and that's when he saw the swelling and redness.
Pt came to clinic with a reaction to MMR vaccine given at a clinic on Aug 11, 2014. (New pt/no medical or vaccination history)
Pain and Painful contractions  in both legs and hips, any and all muscle groups. pain in knees and some pain in ankles. some burning in leg muscles, numbness and tingling in both legs when getting up from sitting.
Dx with shingles, area face, course about 10d tx - acyclovir and KEFLEX.
Systemic: no issues during observation period-Severe, Additional Details: patient received moderna immunization during the morning of 2/17/2021.  patient was found by facility staff at 2:38pm with no pulse CPR was started, aed was used and ems was called.  time of death 3:15pm
Irregular heart rate lasted several days Shortness of breath while exercising lasted approximately 3 weeks Loss of feeling in fingers - inconsistent but ongoing  Loss of feeling in toes lasted approximately 3 days Bleeding consistent with a menstrual cycle started 8/29 and is still going. Very clotty which is abnormal for me as is any inconsistency in my cycle. Since 8/29 there have only been 4 days where I have not had any bleeding
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Fatigue, swollen glands, swelling at injection site Narrative:
Patient hospitalized with Covid-19 on 5/25/2022 even though fully-vaccinated.  2/3/21- 1st dose 2/24/21- 2nd dose 9/29/21- booster dose
parent noticed resp distress & dyspnea the morning p/vax;pt brought to clinic & sx were resolved upon arrival;pt held for observation w/no subsequent sx;
Two days after vaccines given pt started with rash at site that grew to 8 by 10 cm. Mom very concerned and had to bring child in and miss work.
PATIENT REPORTED NAUSEA AND MEDICINAL/WEIRD TASTE IN HER MOUTH.  BP 138/83 HR 52.  PATIENT RESTED DRANK WATER AND SOME ORANGE JUICE.
Pt's mother reports rash like bumps around site of injection today after immunization received yesterday (09/22/08). Reports no s/s of shortness of breath, etc. Has notified physician.
Within minutes, I felt strange ... went to car and left side of face /eye went numb... and left hand ... lasted hour or so and felt ok... however the next day, I had 102.7 fever which lasted another day .
Patient is complaining that her arm still hurts at injection site and now the pain has spread to her shoulder and neck area. She said she missed 3 days of work.
Woke up (6a) with head ache, body aches, loss of appetite, fuzzy thinking, raised hard area at injection site - 5in long, 3in wide - slept most of day.  Symptoms mostly gone by 3/2 7am, with exception of raised area at injection site and mild fuzzy thinking.  Took two tylenol for headache 6p
pt recvd vax for prophylaxis; 8 days later exp pain radiating from lt neck to shoulder & below deltoid; no tx given;reporting MD states sxs resolved & that pt was seen 18jul94 w/o complaint;
He complains of a moderately severe headache for 1 week(s).   Location: bilateral in the frontal area and back of neck and upper back. Associated signs and symptoms include nausea x 1 day + fever.
Flu-like sx w/generalized muscular aching & exaggerated arthritic type pain; Also chills;
Symptoms began with tingling to both shoulders and arms with decreased sensation to both, several hours later after initial onset both legs had decreased sensation and tingling and muscle rigidity began with tightening of the jaw muscles first then moved downward with rigidity to arms and legs with feelings of uncoordination. The following day there were still residual intermittent tingling sensation to all extremities and muscle fatigue, rigidity had lessened.  To this date there is still residual muscle fatigue with random tingling sensations and muscle pain the pain being mostly in the both legs. Employee Health contacted on Friday morning 9/20/2013 to report event.  Primary Care Physician notified Monday 9/22/2013.
This spontaneous report has been received from a female patient (who was also a medical assistant) in her 30s reporting on herself, via company representative. No information regarding the patient's medical history or concurrent conditions was provided. On an unknown date in March 2014, the patient was vaccinated with a dose of GARDASIL injection (dose, lot # and expiry date were not reported). The patient stated that the dose of the vaccine was administered in her synovial bursa instead of deltoid muscle. There were no concomitant therapies reported. On an unknown date in 2014, the patient experienced shoulder pain. She had been in physical therapy for "quite some time" due to the event. The outcome of the event of shoulder pain was reported as not recovered. The relatedness between GARDASIL was not provided. Additional information has been requested.
Pain at Injection Site, Bad Headache, Joint and Muscle Aches and Pain, 99.7 temperature, Slight Labor in Breathing, Pulse 86 Beats per Minute (at rest), Fatigue/Tiredness, Brain Fog
Passed out; Does not want to get 2nd dose; Head was hurting; Mini stroke; Speech difficulties; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) and CEREBROVASCULAR ACCIDENT (Mini stroke) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included LOSARTAN, LEVOCETIRIZINE, TEMAZEPAM, ATORVASTATIN CALCIUM (LIPITOR), BISOPROLOL and BUSPIRONE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criteria hospitalization and medically significant). On 01-Apr-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Mini stroke) (seriousness criteria hospitalization and medically significant), SPEECH DISORDER (Speech difficulties) and HEADACHE (Head was hurting). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Does not want to get 2nd dose). The patient was hospitalized from 01-Apr-2021 to 04-Apr-2021 due to CEREBROVASCULAR ACCIDENT and LOSS OF CONSCIOUSNESS. At the time of the report, LOSS OF CONSCIOUSNESS (Passed out), CEREBROVASCULAR ACCIDENT (Mini stroke), SPEECH DISORDER (Speech difficulties) and HEADACHE (Head was hurting) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Does not want to get 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included generic Plavix and blood thinner.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fatigue,headache,muscle pain, joint pain, chills, nausea / vomiting , fever ,dry mouth.
End of July 2013 pt with cough, chills, fever, rhinitis and sore throat. Rx with antibiotic, cough syrup - cough continued until Oct 2013 with low grade fever at times then resolved - Reports cough in 20 Dec 2012 .
The patient felt fine immediately after the vaccine which was at 3pm 2/10. She reports having difficulty sleeping and awoke with a headache. When she got out of bed, a few after getting up, she felt dizzy and decided to get back in bed however she fainted and fell onto the floor. She also reports nausea.
Information has been received from a registered nurse concerning a 10 year old female patient with no pre existing allergies or medical conditions, who on 5/26/1998 was vaccianted with a first dose of varicella virus vaccine live. It was noted that at the time of vaccination the patient had strept throat and headache. On 6/6/2005 the patient broke out, and on 6/7/05 at a physician appointment there were approximately 50 vesicle lesions over her abdomen and a few on her scalp. The patient was also diagnosed with pharyngitis at the physician office visit. A strept quick test and throat culture were negative. It was noted that the patient did not have adverse events following prior vaccination. The patients outcome is recovered. No additional information is expected.
This spontaneous report was received from a certified medical assistant concerning an approximately 8 week old patient of unknown gender. On 18-MAR-2013, the patient was vaccinated with a dose of MMR II (lot number and expiry date reported as H015829 and August 2014 respectively, dose unspecified), subcutaneously instead of a polio vaccine (manufacturer unspecified). No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Patient was given a dose of Shingrix vaccine that was 22 days past its expiration date. No adverse reactions known.
felt pretty bad in head all night....next morning feel a little better...minor headache......I took some Excedrin migraine  1 tab every 4 hrs  Are really sore
Got first dose of vaccine on 12feb21 and still did not get second dose on 29jun21; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a non-health professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got first dose of vaccine on 12feb21 and still did not get second dose on 29jun21) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got first dose of vaccine on 12feb21 and still did not get second dose on 29jun21). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got first dose of vaccine on 12feb21 and still did not get second dose on 29jun21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. no concomitant medications are provided. Reporter stated that the patient was suffers from an autoimmune disease and she had concern on 2nd dose.
Approximately 5-7days after Johnson/Johnson COVID 19 Vaccine, mild pain has appeared to my left arm, and now it?s been 2mo., that pain much much worse, and unable to move in certain position.  I?m very high tolerance to pain and hope it will go away but now at times its extremely unbearable.  NOT sure, this left arm pain is due to vaccine, but this pain did  appeared 5-7 days after JJ injection.   At first, I thought it maybe sympathy pain since the injection was received on my right arm.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a female of unspecified age. Initial information was processed along with additional information received on 20-MAY-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, 1 total was administered in right arm on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 18-MAY-2022, the patient started developing symptoms. The patient had chest pain with cough, and felt tired. The patient was tested positive to covid-19 (confirmed covid-19 infection) and hence confirmed clinical vaccination failure. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This case was associated with product quality complaint: 90000232251.; Sender's Comments: V0:20220540807-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Patient received 12 years and older dose of Pfizer COVID-19 vaccine as the first dose.  Mother stated patient had headache and body aches.
Upon administering both vaccinations on the left side of the arm, a localized swelling at injection site began to form. Swelling was hard to the touch but painless for patient. Patient reported no other ill-feeling, was breathing fine. Provided an icepack to hold to swelling and contact their physician who agreed for her to come for further assessment.  Called patient to check in later in the evening - physician advised patient to take anti-histamine for the reaction and take Tylenol for pain. If does not get better can take Benadryl. Patient also reported feeling lightheaded/dizzy.
2:15 - Altered mental status, responsive to verbal, c/o and pain and "indigestion" 2:16 - Loss of consciousness & urinary incontinence, EMS activated 2:17 -  Transported via wheelchair to treatment room 2:20 - A&O x 3, EKG (Normal sinus rhythm) 2:25 - EMS on scene, Patient signed Against Medical Advise form.  EMS released patient to friend to be transported home via POV
Vaccine may have been stored under conditions that departed from the manufacturer's recommended specifications. Pharmacy consulted with the vaccine manufacturer regarding this issue.  In such a circumstance, the manufacturer deems the vaccine not to be viable.  Additionally, the CDC recommends that patient repeat 1 dose of the same COVID-19 vaccine immediately (no minimum interval). Patient may not have received the full benefits of the vaccine. The additional dose is provided at no cost. Patient will call back when he can return to get additional dose.
No additional adverse events.; multiple doses of VAQTA administered since temperature excursion that occurred 16JUN202; This spontaneous report was received from a consumer and refers to a patient of unknown age and gender. The patient's medical history, concomitant therapies and concurrent conditions were not provided.  On 05-JUL-2022, the patient was vaccinated with 1 dose of improperly stored hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, prefilled syringe, lot # U012678, expiration date 18-JAN-2023 (exact dose, dose number, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered hepatitis a vaccine, inactivated (VAQTA) underwent temperature excursion that took place on 16-JUN-2022 with 8.5 Celsius degrees for 10 minutes. Previous temperature excursion took place on an unknown date in May 2022 with 8.8 Celsius degrees for 11 minutes. No additional adverse events were reported (no adverse event).  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2207USA004234: US-009507513-2207USA004244: US-009507513-2207USA004698: US-009507513-2207USA004700: US-009507513-2207USA001345: US-009507513-2207USA004691: US-009507513-2207USA004707: US-009507513-2207USA004690: US-009507513-2207USA004688: US-009507513-2207USA004679: US-009507513-2207USA004695: US-009507513-2207USA004697: US-009507513-2207USA004710: US-009507513-2207USA004712: US-009507513-2207USA004714: US-009507513-2207USA004715:
I felt the injection was given too high in my deltoid. I felt a burning sensation and then the administrator pull back on the syringe and then continued to inject. It felt like it was a much longer process then previously experienced with flu shots. I have had terrible pain in my right shoulder and upper arm since the vaccine, with very limited mobility.
sick; chills; tired; sneezing like crazy; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that she had been sick due to the reaction to her COVID vaccine, chills, tired and sneezing like crazy. The outcome of events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
redness below the site of injection/A lot of redness/below the injection site; Some inflammation in the area below the injection sites; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 66-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: GA5915, Expiration Date: Jan2024) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), 8 days after the suspect product(s) administration, outcome "unknown", described as "redness below the site of injection/A lot of redness/below the injection site"; VACCINATION SITE INFLAMMATION (non-serious), 8 days after the suspect product(s) administration, outcome "unknown", described as "Some inflammation in the area below the injection sites". Additional information: There was a patient, he's received a Prevnar 20 vaccination and 8 days later they are reporting that they have like a lot of redness and some inflammation in the area below the injection site. He just wanted to ask if that's considered normal, that's something need to advice them, to advice the patient to seek some medical attention.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 12 year old female who on 24-Mar-2008 was vaccinated SC with a second 0.5ml dose of VARIVAX (Merck) (lot number 659170/1501U). Concomitant therapy given on the same visit, included a dose of Human papilomavirus vaccine (MSD). On 25-Mar-2008, shortly after the vaccination, the patient developed redness, pain, warmth and swelling at the injection site. The patient was seen several days later by the physician and all symptoms had resolved. The outcome was reported as recovered. There was no product quality complaint. Additional information has been received from the physician who reported that the patient's symptoms were gone in 72 hours. There were no problems and the patient was doing well. No further information is expected.
Patient received his second covid dose (Moderna) 20 days from the first dose (Pfizer).
During a Pfizer vaccine and flu shot clinic, the administering RPh administered a Pfizer booster shot to a patient who had Moderna as his primary COVID vaccination series. The first Moderna shot was on 2/19/21, and second shot on 3/19/21. Administering RPh felt like patient was pressuring him to administer quickly d/t longer wait times and did not look at patient's consent form or CDC vaccine record card prior to administration. The error was noticed immediately after vaccination and patient was counseled on the error.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 2 month old female patient with no drug reactions/allergies and no pertinent medical history who on 12-JAN-2012, was vaccinated with a first dose of ROTATEQ, oral, (lot number 670539/0678AA, expiration date 15-MAR-2013), (dose not reported) and spitted it up. There was no treatment given for spitting up. At the time of the report the patient's outcome was unknown. The patient did not seek medical attention. Additional information has been requested.
Patients shot was 11:30,  Tuesday 12/ 29.  Complained of arm ache starting at 16:30. On 12/20 at 8:00, body aches started. Had chills at 19:00-21:00.  Took Aleve and went to bed.  Feels good today, 12/31, but arm is tender to the touch with a little red 2cm spot at injection site.
Patient developed rash on Left side of body from neck to torso 2 days after flu shot.  Patient did not have any issues at time of vaccination and barely felt the needle
runny nose and sore throat like a cold; runny nose; sore throat; tired; sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An adult female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 19Oct2023 as dose 1, single (Lot number: HF9275) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: bnt162b2 (DOSE 4 (BOOSTER), SINGLE), administration date: 12Sep2022, for COVID-19 immunization, reaction(s): "no reactions"; bnt162b2 (DOSE 3 (BOOSTER), SINGLE), administration date: 11Oct2021, for COVID-19 immunization, reaction(s): "no reactions"; bnt162b2 (DOSE 2, SINGLE), administration date: 05Mar2021, for COVID-19 immunization, reaction(s): "no reactions"; bnt162b2 (DOSE 1, SINGLE), administration date: 12Feb2021, for COVID-19 immunization, reaction(s): "no reactions". The following information was reported: RHINORRHOEA (non-serious) with onset 21Oct2023, outcome "unknown", described as "runny nose"; NASOPHARYNGITIS (non-serious) with onset 21Oct2023, outcome "unknown", described as "runny nose and sore throat like a cold"; SOMNOLENCE (non-serious) with onset 21Oct2023, outcome "unknown", described as "sleeping"; OROPHARYNGEAL PAIN (non-serious) with onset 21Oct2023, outcome "unknown", described as "sore throat"; FATIGUE (non-serious) with onset 21Oct2023, outcome "unknown", described as "tired". Additional information: The patient got vaccination on Thursday, 19Oct2023, and it says on the vaccination card: "Pfizer Comirnaty HF9275".  The patient has had four Pfizer COVID 19 vaccines previously with no reactions, until this most recent one on 19Oct2023. She got this dose 5 on 19Oct2023 of "Pfizer Comirnaty HF9275" and have developed symptoms of runny nose and sore throat like a cold, which she usually didn't get and was not normal for her. The patient stated that she just tired, sleeping and runny nose. She got these symptoms 2 days after vaccination.  She confirmed she is an adult patient.